Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea

As hypoxia-induced inflammatory angiogenesis may contribute to sickle cell disease manifestations, we compared the angiogenic molecular profiles of plasma from sickle cell disease individuals and correlated these with in vitro endothelial cell-mediated angiogenesis-stimulating activity and in vivo neovascularization. Bioplex demonstrated that plasma from steady-state sickle cell anemia patients presented elevated concentrations of pro-angiogenic factors (Angiopoietin-1, basic fibroblast growth factor, vascular endothelial growth factor, vascular endothelial growth factor-D and placental growth factor) and displayed potent pro-angiogenic activity, significantly augmenting endothelial cell proliferation, migration and capillary-like structure formation. In vivo neovascularization of Matrigel plugs was significantly greater in sickle cell disease mice, compared with non-sickle cell disease mice, consistent with an upregulation of angiogenesis in the disease. In plasma from patients with hemoglobin SC disease without proliferative retinopathy, anti-angiogenic endostatin and thrombospondin-2 were significantly elevated. In contrast, plasma from hemoglobin SC individuals with proliferative retinopathy displayed a pro-angiogenic profile and had more significant effects on endothelial cell proliferation and capillary formation than plasma of patients without retinopathy. Hydroxyurea therapy was associated with significant reductions in plasma angiogenic factor profile, in association with an inhibition of endothelial cell-mediated angiogenic mechanisms and neovascularization. Thus, sickle cell anemia and retinopathic hemoglobin SC individuals present a highly angiogenic circulating milieu, capable of stimulating key endothelial cell-mediated angiogenic mechanisms. Combination anti-angiogenic therapy for preventing progression of unregulated neovascularization and associated manifestations in sickle cell disease, such as pulmonary hypertension, may be indicated; furthermore, the benefits and drawbacks of the potent anti-angiogenic effects of hydroxyurea should be clarified.As hypoxia-induced inflammatory angiogenesis may contribute to sickle cell disease manifestations, we compared the angiogenic molecular profiles of plasma from sickle cell disease individuals and correlated these with in vitro endothelial cell-mediated an1006730739FAPESP - FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCNPQ - CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO2008/57441-0; 2009/16334-0565036/201

Avaliação da atividade imunológica de Achillea millefolium L. ("mil-folhas")

Macrófagos são as primeiras células a participarem da resposta imunológica, e quando são ativados liberam mais de cem compostos ao meio extracelular, entre os compostos reativos intermediários de nitrogênio (NO). Neste trabalho determinou-se a liberação de óxido nítrico em culturas de macrófagos peritoneais de camundongos em presença de óleo essencial bruto e extrato etanólico 70% bruto obtidos a partir de folhas de Achillea millefolim L. (Asteraceae). Diferentes diluições do óleo essencial foram testadas (1:50, 1:100 e 1:200). Apenas a diluição 1:100 produziu uma maior quantidade de óxido nítrico (NO). em relação ao extrato etanólico 70%, observou-se nas amostras mais concentradas (6 mg/mL, 8 mg/mL e 10 mg/mL) maior produção de NO. Analisando-se os resultados obtidos no presente trabalho, pode-se sugerir que tanto o óleo essencial quanto o extrato etanólico 70% bruto de A. millefolium L são agentes moduladores da ativação de macrófagos, nas concentrações de 20, 10 e 5 mg/mL, quando comparado com LPS (lipopolissacarídeo-potente estimulador da produção de NO)